Navigation Links
Amgen's Second Quarter 2013 Revenues Increased 5 Percent To $4.7 Billion And Adjusted Earnings Per Share (EPS) Increased 3 Percent To $1.89
Date:7/30/2013

THOUSAND OAKS, Calif., July 30, 2013 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced financial results for the second quarter of 2013.  Key results for the quarter include:

  • Total revenues increased 5 percent to $4,679 million, with 9 percent product sales growth driven by Enbrel® (etanercept), Neulasta® (pegfilgrastim), XGEVA® (denosumab), and Prolia® (denosumab).  Product sales included a positive adjustment of $185 million to previous estimates for managed Medicaid rebates based on recent claims experience.  Other revenues were lower by $193 million as a result of a payment from Takeda recognized in the second quarter of 2012.
  • Adjusted EPS grew 3 percent to $1.89, with higher revenues and a lower tax rate partially offset by increased Research & Development (R&D) investment.  Adjusted net income increased 1 percent to $1,444 million.
  • GAAP EPS were $1.65 compared to $1.61 and GAAP net income was $1,258 million compared to $1,266 million.
  • The Company generated approximately $1.4 billion of free cash flow.
  • "We saw solid product trends during the second quarter and are carrying good momentum into the second half," said Robert A. Bradway, chairman and chief executive officer at Amgen. "We continue to make excellent progress with our pipeline of innovative molecules and look forward to multiple data readouts in 2014, including pivotal Phase 3 data for our cholesterol-lowering agent, AMG 145, in the first quarter."Year-over-Year$Millions, except EPS and percentagesQ2 '13Q2 '12YOY ΔTotal Revenues$4,679$4,4775%Adjusted Net Income1,4441,4331%Adjusted EPS1.891.833%GAAP Net Income1,2581,266(1%)GAAP EPS$1.65$1.612%References in this release to "adjusted" measures, measures presented "on an adjusted basis" or to free cash flow refer
    '/>"/>

    SOURCE Amgen
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

    Related medicine technology :

    1. Covance Reports Second Quarter Net Revenue of $592 Million, Pro Forma EPS of $0.78 and Record Adjusted Net Orders of $776 Million
    2. Oncology remains most restrictive specialty for second year
    3. China Biologic Products to Report Second Quarter 2013 Financial Results
    4. Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2013 Second Quarter Financial Results
    5. Vanda Pharmaceuticals to Announce Second Quarter 2013 Financial Results on July 31, 2013
    6. Webcast Alert: Isis Pharmaceuticals Second Quarter 2013 Financial Results Conference Call
    7. VirtualScopics Schedules Second Quarter 2013 Earnings Announcement
    8. Luminex Corporation Reports Second Quarter 2013 Results
    9. Endo to Announce Second Quarter 2013 Financial Results on August 6, 2013
    10. Simcere Pharmaceutical Group to Announce Second Quarter 2013 Financial Results on Tuesday, August 13, 2013
    11. PDI, Inc. to Hold Second Quarter 2013 Financial Results Conference Call on Monday, August 5, 2013
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/31/2015)... IRVINE, Calif. , Aug. 31, 2015 /PRNewswire/ ... business and government, where regulations are often strict ... environment is driving a demand for professionals who ... interpret these regulations across a product lifecycle and ... organization. The University of California, Irvine Extension ...
    (Date:8/31/2015)... FLINT, Mich. , Aug. 31, 2015  Diplomat Pharmacy, ... pharmacy, has announced that Phil Hagerman , Chairman & ... four upcoming investor conferences. Mr. Hagerman and ... 2015 Healthcare Conference in Boston on ... Mr. Hagerman and Mr. Whelan are also scheduled to participate ...
    (Date:8/31/2015)... , Aug. 31, 2015  Qualcomm Incorporated ... subsidiary, Qualcomm Life, Inc., is collaborating ... chronic care management solutions powered by Qualcomm Life,s ... Platform to enable continuous care, informed interventions and ... announced at Qualcomm Life,s annual Connect 2015 ...
    Breaking Medicine Technology:UC Irvine Extension Launches New Regulatory Affairs and Compliance Certificate Program 2UC Irvine Extension Launches New Regulatory Affairs and Compliance Certificate Program 3Diplomat to Participate in Upcoming Investor Conferences 2Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 2Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 3Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 4Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 5
    ... 2011 Reportlinker.com announces that a new market research ... Global Injectable Drug Delivery Market (2010 - 2015) ... KEY TAKE AWAYS * To ... its various sub-segments with respect to types of systems, ...
    ... Reportlinker.com announces that a new market research report ... European Markets for Minimally Invasive Spinal Devices ... The European minimally invasive spinal implant ... Rapid growth of the MIS interbody and MIS ...
    Cached Medicine Technology:Reportlinker Adds Global Injectable Drug Delivery Market (2010 - 2015) 2Reportlinker Adds Global Injectable Drug Delivery Market (2010 - 2015) 3Reportlinker Adds European Markets for Minimally Invasive Spinal Devices 2011 2
    (Date:9/1/2015)... ... 2015 , ... A new episode of “Voices In America”, hosted by famous ... topic of arthritis. There are over 100 different types of arthritis. One of the ... in an effort to shed light on this important topic. , Anyone who is ...
    (Date:9/1/2015)... ... , ... The premier online medical education company for Podiatrists ... podiatric, surgical and wound care conferences . The Residency Education Summits standardize ... the podium and across the table during hands-on surgical and advanced wound care ...
    (Date:8/31/2015)... Orange, NJ (PRWEB) , ... September 01, 2015 ... ... the spine to eliminate chronic back pain – once required a long, arduous ... a shorter hospital stay, less pain, less blood loss and minimal muscle damage. ...
    (Date:8/31/2015)... ... August 31, 2015 , ... ITC ... wealth of information for specific translation services within the medical and pharmaceutical industries. ... track record of successful work. , ITC Global Translations specializes in professional translation ...
    (Date:8/31/2015)... ... , ... In an article based on a reader’s question that ... of treating back pain caused by a disrupted disk by using steroids rather than ... function in patients suffering from a herniated disk, the level of pain that patients ...
    Breaking Medicine News(10 mins):Health News:PRESENT e-Learning Systems Announces their 2016 Podiatry and Wound Care Medical Education Conference Schedule 2Health News:Minimally Invasive Spinal Fusions Squash Back Pain without Arduous Recovery 2Health News:Minimally Invasive Spinal Fusions Squash Back Pain without Arduous Recovery 3Health News:Minimally Invasive Spinal Fusions Squash Back Pain without Arduous Recovery 4Health News:GoMarketing Announces Major Updates to ITC Global Translations Website http://www.ITCGlobalTranslations.com 2Health News:GoMarketing Announces Major Updates to ITC Global Translations Website http://www.ITCGlobalTranslations.com 3Health News:Article on Steroid Use for Back Pain Highlights the Effectiveness of Surgery in Treating Disk Pain, says Dr. Seyed M. Rezaian 2
    ... and Rainbow,Kitchen Community Services announced today that they ... Against Hunger" on Saturday, April 26, 2008.,The event ... and services, and raises public awareness about the,benefits ... participants can either walk or ride bicycles,along the ...
    ... April 24 Prime Therapeutics (Prime), a,thought leader ... RPh, has joined the organization as Vice President ... Pharmacy Trade Relations, Wan will focus on,developing and ... Prime,s efforts in the development of strategic pharmacy,contracts ...
    ... Frankfurt: I7VF), INVERNESS, Scotland, April 24 /PRNewswire-FirstCall/ - ... sheet restructuring,leaving it free of all loan note indebtedness, ... to enable it to move forward. The Company has,been ... 2005., Medical Diagnostic Innovations Ltd, a UK investment ...
    ... (Nasdaq: STAA ) today announced that it will ... 2008 on Tuesday, May 6, 2008,after the market close. ... Tuesday, May 6, 2008 at 5:00 p.m. Eastern Time ... The dial-in number for,the conference call is 866-250-3615 for ...
    ... 24 The Quigley,Corporation (Nasdaq: QGLY ) today ... the first quarter ended March 31, 2008,compared to $6.1 ... The first quarter of 2008 reflects a net sales ... compared to the first quarter,of 2007. The change during ...
    ... ) announced that it will release first quarter 2008,financial results on Thursday, ... The Company will host a conference call to discuss the first ... First Quarter 2008 Earnings Conference Call, ... Thursday, May 1, 2008 at 5:00 p.m. Eastern Time, Dial-in: ...
    Cached Medicine News:Health News:UPMC Health Plan and Rainbow Kitchen Community Services at 'W.A.R.' to Wipe Out Hunger in Pittsburgh 2Health News:UPMC Health Plan and Rainbow Kitchen Community Services at 'W.A.R.' to Wipe Out Hunger in Pittsburgh 3Health News:IVMD Inc. Announces Fundamental Balance Sheet Restructuring. 2Health News:IVMD Inc. Announces Fundamental Balance Sheet Restructuring. 3Health News:STAAR Surgical Announces First Quarter 2008 Earnings Release Date and Conference Call 2Health News:The Quigley Corporation Reports First Quarter 2008 Results - Increases Investment in Pharmaceutical R&D Future 2Health News:The Quigley Corporation Reports First Quarter 2008 Results - Increases Investment in Pharmaceutical R&D Future 3Health News:The Quigley Corporation Reports First Quarter 2008 Results - Increases Investment in Pharmaceutical R&D Future 4Health News:The Quigley Corporation Reports First Quarter 2008 Results - Increases Investment in Pharmaceutical R&D Future 5
    High speed, programmable refrigerated centrifuge. High efficiency separations, "Like clockwork" accuracy, aerosol containment, Accommodating, Re-Run control, Glove-Friendly membrane, centrifuge statu...
    ... 460 family of centrifuges ... that meets a wide ... feature high capacity, versatility ... technology and high safety ...
    The Quantum performs centrifugal blood cell separations, urine separations, and sperm cell washing. 24 place angle head, variable speed, and automatic braking system, calibrated variable speed....
    ... centrifuge is designed especially for ... cover with safety interlock switch, ... emissions, "hold" position for continuous ... motor, maximum stability and compact, ...
    Medicine Products: